
netupitant-palonosetron oral brand names and other generic formulations include:
Akynzeo Oral
sonidegib oral brand names and other generic formulations include:
Odomzo Oral
netupitant-palonosetron oral and sonidegib oral
netupitant-palonosetron oral will increase the level or effect of sonidegib oral by altering drug metabolism. Avoid this combination. If sonidegib must be combined with this drug give the interacting drug for less than 14 days and monitor closely for adverse reactions, particularly musculoskeletal adverse reactions.
netupitant-palonosetron oral and sonidegib oral
netupitant-palonosetron oral will increase the level or effect of sonidegib oral by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid coadministration of sonidegib with moderate CYP3A4 inhibitors. If a moderate CYP3A inhibitor must be used, administer the moderate CYP3A inhibitor for <14 days and monitor closely for adverse reactions, particularly musculoskeletal adverse reactions.
Check for more interactions with the Drug Interaction Checker
Drug Interaction Categories
Contraindicated
Never use this combination of drugs because of high risk for dangerous interaction
Serious
Potential for serious interaction; regular monitoring by your doctor required or alternate medication may be needed
Significant
Potential for significant interaction (monitoring by your doctor is likely required)
Minor
Interaction is unlikely, minor, or nonsignificant